Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15939062rdf:typepubmed:Citationlld:pubmed
pubmed-article:15939062lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C0051405lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C1531719lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:15939062lifeskim:mentionsumls-concept:C2745888lld:lifeskim
pubmed-article:15939062pubmed:issue1lld:pubmed
pubmed-article:15939062pubmed:dateCreated2005-6-7lld:pubmed
pubmed-article:15939062pubmed:abstractTextWe tested the hypothesis that dietary alpha-linolenic acid (ALA) can exert effects on markers of cardiovascular risk similar to that produced by its longer chain counterparts in fish-oil. A dietary intervention study was undertaken to examine the effects of an ALA-enriched diet in 57 men expressing an atherogenic lipoprotein phenotype (ALP). Subjects were randomly assigned to one of three diets enriched either with flaxseed oil (FXO: high ALA, n = 21), sunflower oil (SO: high linoleic acid, n = 17), or SO with fish-oil (SOF n = 19) for 12 weeks, resulting in dietary intake ratios of n-6:n-3 PUFA of 0.5, 27.9 and 5.2, respectively. The relative abundance of ALA and EPA in erythrocyte membranes increased on the FXO diet (p < 0.001), whereas both EPA and DHA increased after fish-oil (p < 0.001). There were significant decreases in total plasma cholesterol within (FXO -12.3%, p = 0.001; SOF -7.6%, p = 0.014; SO -7.3%, p = 0.033) and between diets (p = 0.019), and decreases within diets after 12 weeks for HDL cholesterol on flaxseed oil (FXO -10%, p=0.009), plasma TG (-23%, p < 0.001) and small, dense LDL (-22% p = 0.003) in fish-oil. Membrane DHA levels were inversely associated with the changes in plasma TG ( p= 0.001) and small, dense LDL (p<0.05) after fish-oil. In conclusion, fish-oil produced predictable changes in plasma lipids and small, dense LDL (sdLDL) that were not reproduced by the ALA-enriched diet. Membrane DHA levels appeared to be an important determinant of these fish-oil-induced effects.lld:pubmed
pubmed-article:15939062pubmed:languageenglld:pubmed
pubmed-article:15939062pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:citationSubsetIMlld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15939062pubmed:statusMEDLINElld:pubmed
pubmed-article:15939062pubmed:monthJullld:pubmed
pubmed-article:15939062pubmed:issn0021-9150lld:pubmed
pubmed-article:15939062pubmed:authorpubmed-author:MillerGeorge...lld:pubmed
pubmed-article:15939062pubmed:authorpubmed-author:GriffinBruce...lld:pubmed
pubmed-article:15939062pubmed:authorpubmed-author:MillwardD...lld:pubmed
pubmed-article:15939062pubmed:authorpubmed-author:WilkinsonPaul...lld:pubmed
pubmed-article:15939062pubmed:authorpubmed-author:LeachClareClld:pubmed
pubmed-article:15939062pubmed:authorpubmed-author:Ah-SingEric...lld:pubmed
pubmed-article:15939062pubmed:authorpubmed-author:HussainNahedNlld:pubmed
pubmed-article:15939062pubmed:issnTypePrintlld:pubmed
pubmed-article:15939062pubmed:volume181lld:pubmed
pubmed-article:15939062pubmed:ownerNLMlld:pubmed
pubmed-article:15939062pubmed:authorsCompleteYlld:pubmed
pubmed-article:15939062pubmed:pagination115-24lld:pubmed
pubmed-article:15939062pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:meshHeadingpubmed-meshheading:15939062...lld:pubmed
pubmed-article:15939062pubmed:year2005lld:pubmed
pubmed-article:15939062pubmed:articleTitleInfluence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype.lld:pubmed
pubmed-article:15939062pubmed:affiliationCentre for Nutrition and Food Safety, School of Biomedical and Molecular Sciences, University of Surrey, Guildford, UK.lld:pubmed
pubmed-article:15939062pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15939062pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15939062pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15939062pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15939062lld:pubmed